Zila
This article was originally published in The Tan Sheet
Executive Summary
Douglas Burkett, PhD, named VP-pharmaceuticals & development May 2. Burkett will oversee Zila's Innovative Swab Technologies division and Zila Technical Operations, as well as Zila Pharmaceuticals, which includes the Phoenix-based company's professional and consumer pharmaceuticals businesses. Burkett began his career at Zila in 1995 as manager of research & manufacturing; he most recently served as VP of the Technical Operations division. Zila's products include Zilactin canker sore and oral pain remedies...
You may also be interested in...
Zila Ester-C Ad Campaign Features Radio, TV Spots Debuting This Fall
Zila, Inc. division Inter-Cal Nutraceuticals will launch a nine-month national advertising campaign this fall for its Ester-C supplement ingredient
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.